Antimicrobial susceptibilities of Campylobacter jejuni isolates from hospitalized children in Athens, Greece, collected during 2004-2005.
A total of 170 Campylobacter jejuni strains isolated from the stool of children with clinical gastroenteritis, aged from 3 months to 14 years, were collected during a two-year period (2004-2005). From the 170 strains 30% were resistant to ciprofloxacin (MIC > or = 4 microg/ml), 55% to tetracycline (MIC > 8 microg/ml), 13% to clindamycin (MIC > or = 8 microg/ml), 4% to ampicillin (MIC > 16 microg/ml), 6% to erythromycin (MIC > or = 8 microg/ml), 4% to coamoxiclav (MIC > or = 16/8 microg/ml) and 0% to gentamicin. Compared to previous reports from Greece, the antimicrobial resistance rates to erythromycin, ampicillin and coamoxiclav remain low, while they are still high for tetracycline and ciprofloxacin. Considering similar reports from many other countries and the high incidence of Campylobacter gastroenteritis worldwide, the value of ciprofloxacin as a first choice drug in the empiric treatment of the infection is questionable.
Papavasileiou
Eleni
E
Voyatzi
Aliki
A
Papavasileiou
Konstantina
K
Makri
Antonia
A
Andrianopoulou
Ioanna
I
Chatzipanagiotou
Stylianos
S
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002169:Campylobacter Infections / Q000382:microbiology*; D016123:Campylobacter jejuni / Q000302:isolation & purification* / Q000502:physiology*; D002648:Child; D002675:Child, Preschool; D024901:Drug Resistance, Multiple, Bacterial; D005243:Feces / Q000382:microbiology; D005260:Female; D005759:Gastroenteritis / Q000382:microbiology; D006115:Greece / Q000453:epidemiology; D006761:Hospitals; D006801:Humans; D007223:Infant; D008297:Male; D008826:Microbial Sensitivity Tests
D000900:Anti-Bacterial Agents